In ovarian clear-cell carcinomas, 40% of tumors harbor PIK3CA somatic mutations and the majority of these were ARID1A-deficient tumors (Yamamoto et al., 2012). The gene discussed is PIK3CA; the disease is ovarian clear cell cancer.